Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 10/2014

01.10.2014 | Retinal Disorders

Retinal venous pressure in the non-affected eye of patients with retinal vein occlusions

verfasst von: Maneli Mozaffarieh, M. Bärtschi, P. B. Henrich, A. Schoetzau, J. Flammer

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

To measure the retinal venous pressure (RVP) in both eyes of patients with unilateral central retinal vein occlusions and to compare these values to controls.

Methods

The study included 31 patients with unilateral central retinal vein occlusions (CRVO) and 31 controls who were matched by age, sex, and systemic disease. RVP was measured in all patients bilaterally by means of contact lens ophthalmodynamometry, and the RVP measurements of the affected and unaffected eyes of patients were compared to the RVPs of controls. Ophthalmodynamometry is done by applying an increasing pressure on the eye via a contact lens. The minimum force required to induce a venous pulsation is called ophthalmodynamometric force (ODF). The RVP is defined and calculated as the sum of ODF and intraocular pressure (IOP) [RVP = ODF + IOP].

Results

The RVP group means ± SD were as follows: patient’s affected eyes (45.0 ± 11.6 mmHg), patient’s unaffected eyes (38.0 ± 11.1 mmHg) ,and (17.7 ± 6.7 mmHg) in the eyes of controls. The values of RVP, even in the patients unaffected eyes, were significantly higher than in the eyes of controls (P < 0.001).

Conclusions

In patients with CRVO, the RVP is increased in both the affected as well as in the unaffected contralateral eye.
Literatur
1.
Zurück zum Zitat Napal Lecumberri JJ, Sedano Balbas C, Canal Villanueva J, Hernandez Hernandez JL (2013) Thrombophilia and vascular risk factors in retinal vein occlusion. Rev Clin Esp 213(5):229–234 (article in English/Spanish)PubMedCrossRef Napal Lecumberri JJ, Sedano Balbas C, Canal Villanueva J, Hernandez Hernandez JL (2013) Thrombophilia and vascular risk factors in retinal vein occlusion. Rev Clin Esp 213(5):229–234 (article in English/Spanish)PubMedCrossRef
2.
Zurück zum Zitat Zhou JQ, Xu L, Wang S, Wang YX, You QS, Tu Y et al (2013) The 10-year incidence and risk factors of retinal vein occlusion: the Beijing Eye Study. Ophthalmology 120(4):803–808PubMedCrossRef Zhou JQ, Xu L, Wang S, Wang YX, You QS, Tu Y et al (2013) The 10-year incidence and risk factors of retinal vein occlusion: the Beijing Eye Study. Ophthalmology 120(4):803–808PubMedCrossRef
3.
Zurück zum Zitat Lee JY, Yoon YH, Kim HK, Yoon HS, Kang SW, Kim JG et al (2013) Baseline characteristics and risk factors of retinal vein occlusion: a study by the Korean RVO Study Group. J Korean Med Sci 28(1):136–144PubMedCrossRefPubMedCentral Lee JY, Yoon YH, Kim HK, Yoon HS, Kang SW, Kim JG et al (2013) Baseline characteristics and risk factors of retinal vein occlusion: a study by the Korean RVO Study Group. J Korean Med Sci 28(1):136–144PubMedCrossRefPubMedCentral
4.
Zurück zum Zitat Giannaki K, Politou M, Rouvas A, Merkouri E, Travlou A, Theodosiadis P et al (2013) Retinal vein occlusion: genetic predisposition and systemic risk factors. Blood Coagul Fibrinolysis 24(3):279–283PubMedCrossRef Giannaki K, Politou M, Rouvas A, Merkouri E, Travlou A, Theodosiadis P et al (2013) Retinal vein occlusion: genetic predisposition and systemic risk factors. Blood Coagul Fibrinolysis 24(3):279–283PubMedCrossRef
5.
Zurück zum Zitat McAllister IL, Vijayasekaran S, Yu DY (2013) Intravitreal Tenecteplase (metalyse) (TNK) for acute management of retinal vein occlusions. Invest Ophthalmol Vis Sci 54(7):4910–4918PubMedCrossRef McAllister IL, Vijayasekaran S, Yu DY (2013) Intravitreal Tenecteplase (metalyse) (TNK) for acute management of retinal vein occlusions. Invest Ophthalmol Vis Sci 54(7):4910–4918PubMedCrossRef
6.
Zurück zum Zitat Kadonosono K, Yamane S, Arakawa A, Inoue M, Yamakawa T, Uchio E et al (2013) Endovascular cannulation with a microneedle for central retinal vein occlusion. JAMA Ophthalmol 131(6):783–786PubMedCrossRef Kadonosono K, Yamane S, Arakawa A, Inoue M, Yamakawa T, Uchio E et al (2013) Endovascular cannulation with a microneedle for central retinal vein occlusion. JAMA Ophthalmol 131(6):783–786PubMedCrossRef
7.
Zurück zum Zitat Matonti F, Meyer F, Guigou S, Barthelemy T, Dumas S, Gobert F et al (2013) Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice. Acta Ophthalmol 91(7):e584–e586PubMedCrossRef Matonti F, Meyer F, Guigou S, Barthelemy T, Dumas S, Gobert F et al (2013) Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice. Acta Ophthalmol 91(7):e584–e586PubMedCrossRef
8.
Zurück zum Zitat Lu Y, Su L, Xu X (2013) Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis. J Ocul Pharmacol Ther 29(8):702–708PubMedCrossRef Lu Y, Su L, Xu X (2013) Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis. J Ocul Pharmacol Ther 29(8):702–708PubMedCrossRef
9.
Zurück zum Zitat Huang P, Niu W, Ni Z, Wang R, Sun X (2013) A meta-analysis of anti-vascular endothelial growth factor remedy for macular edema secondary to central retinal vein occlusion. PLoS One 8(12):e82454PubMedCrossRefPubMedCentral Huang P, Niu W, Ni Z, Wang R, Sun X (2013) A meta-analysis of anti-vascular endothelial growth factor remedy for macular edema secondary to central retinal vein occlusion. PLoS One 8(12):e82454PubMedCrossRefPubMedCentral
10.
Zurück zum Zitat Rehak M, Tilgner E, Franke A, Rauscher FG, Brosteanu O, Wiedemann P (2013) Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study). Graefes Arch Clin Exp Ophthalmol [Epub ahead of print] Rehak M, Tilgner E, Franke A, Rauscher FG, Brosteanu O, Wiedemann P (2013) Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study). Graefes Arch Clin Exp Ophthalmol [Epub ahead of print]
11.
Zurück zum Zitat Fraenkl SA, Mozaffarieh M, Flammer J (2010) Retinal vein occlusions: the potential impact of a dysregulation of the retinal veins. EPMA J 1(2):253–261PubMedCrossRefPubMedCentral Fraenkl SA, Mozaffarieh M, Flammer J (2010) Retinal vein occlusions: the potential impact of a dysregulation of the retinal veins. EPMA J 1(2):253–261PubMedCrossRefPubMedCentral
14.
Zurück zum Zitat Jonas JB (2003) Ophthalmodynamometric assessment of the central retinal vein collapse pressure in eyes with retinal vein stasis or occlusion. Graefes Arch Clin Exp Ophthalmol 241(5):367–370PubMedCrossRef Jonas JB (2003) Ophthalmodynamometric assessment of the central retinal vein collapse pressure in eyes with retinal vein stasis or occlusion. Graefes Arch Clin Exp Ophthalmol 241(5):367–370PubMedCrossRef
15.
Zurück zum Zitat Morgan WH, Cringle SJ, Kang MH, Pandav S, Balaratnasingam C, Ezekial D et al (2010) Optimizing the calibration and interpretation of dynamic ocular force measurements. Graefes Arch Clin Exp Ophthalmol 248(3):401–407PubMedCrossRef Morgan WH, Cringle SJ, Kang MH, Pandav S, Balaratnasingam C, Ezekial D et al (2010) Optimizing the calibration and interpretation of dynamic ocular force measurements. Graefes Arch Clin Exp Ophthalmol 248(3):401–407PubMedCrossRef
16.
Zurück zum Zitat Jonas JB, Harder B (2007) Ophthalmodynamometric differences between ischemic vs nonischemic retinal vein occlusion. Am J Ophthalmol 143(1):112–116PubMedCrossRef Jonas JB, Harder B (2007) Ophthalmodynamometric differences between ischemic vs nonischemic retinal vein occlusion. Am J Ophthalmol 143(1):112–116PubMedCrossRef
17.
Zurück zum Zitat Haufschild T, Prunte C, Messerli J, Flammer J (2004) Increased endothelin-1 plasma level in young adults with retinal vascular occlusive diseases. Klin Monatsbl Augenheilkd 221(5):357–359PubMedCrossRef Haufschild T, Prunte C, Messerli J, Flammer J (2004) Increased endothelin-1 plasma level in young adults with retinal vascular occlusive diseases. Klin Monatsbl Augenheilkd 221(5):357–359PubMedCrossRef
18.
Zurück zum Zitat Iannaccone A, Letizia C, Pazzaglia S, Vingolo EM, Clemente G, Pannarale MR (1998) Plasma endothelin-1 concentrations in patients with retinal vein occlusions. Br J Ophthalmol 82(5):498–503PubMedCrossRefPubMedCentral Iannaccone A, Letizia C, Pazzaglia S, Vingolo EM, Clemente G, Pannarale MR (1998) Plasma endothelin-1 concentrations in patients with retinal vein occlusions. Br J Ophthalmol 82(5):498–503PubMedCrossRefPubMedCentral
19.
Zurück zum Zitat Faraco G, Moraga A, Moore J, Anrather J, Pickel VM, Iadecola C (2013) Circulating endothelin-1 alters critical mechanisms regulating cerebral microcirculation. Hypertension 62(4):759–766PubMedCrossRef Faraco G, Moraga A, Moore J, Anrather J, Pickel VM, Iadecola C (2013) Circulating endothelin-1 alters critical mechanisms regulating cerebral microcirculation. Hypertension 62(4):759–766PubMedCrossRef
20.
Zurück zum Zitat Tsui JC, Shi-Wen X (2011) Endothelin-1 in peripheral arterial disease: a potential role in muscle damage. Pharmacol Res 63(6):473–476PubMedCrossRef Tsui JC, Shi-Wen X (2011) Endothelin-1 in peripheral arterial disease: a potential role in muscle damage. Pharmacol Res 63(6):473–476PubMedCrossRef
21.
Zurück zum Zitat Friedman JK, Nitta CH, Henderson KM, Codianni SJ, Sanchez L, Ramiro-Diaz JM et al (2014) Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity. Vasc Pharmacol 60(1):17–24CrossRef Friedman JK, Nitta CH, Henderson KM, Codianni SJ, Sanchez L, Ramiro-Diaz JM et al (2014) Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity. Vasc Pharmacol 60(1):17–24CrossRef
Metadaten
Titel
Retinal venous pressure in the non-affected eye of patients with retinal vein occlusions
verfasst von
Maneli Mozaffarieh
M. Bärtschi
P. B. Henrich
A. Schoetzau
J. Flammer
Publikationsdatum
01.10.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 10/2014
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-014-2617-3

Weitere Artikel der Ausgabe 10/2014

Graefe's Archive for Clinical and Experimental Ophthalmology 10/2014 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.